Boeing’s Results Fly Over Issues, Hess’s Latest Chinese Endeavor, and 3 More Hot Stocks

Boeing Co. (NYSE:BA): Boeing has reported beats for both earnings per share and revenue, with the former clocking at $1.67, 11 cents over projections, and the latter at $21.8 billion, $1.37 billion above estimates. Higher 787 and 737 deliveries led to a 9 percent year-over-year increase in revenue as backlog grows to a record $410 billion riding on $40 billion worth of new orders. Commercial planes saw revenue increase 15 percent, operating margin up 50 basis points, and deliveries  up 13 percent.

ba

Hess Corp. (NYSE:HES): China National Petroleum has announced a partnership with Hess to  develop the Malang oil-and-gas block in northwest China, making it Hess’s latest alliance in the country. No further details were provided, though the talks started last year.

hes

Transition Therapeutics Inc. (NASDAQ:TTHI): Shares are up over 11 percent, as it has “acquired the rights to develop and commercialize a small molecule transcriptional regulator for the treatment of osteoarthritis pain from Eli Lilly (NYSE:LLY),” Seeking Alpha reports. Eli Lilly can reacquire the rights for milestone payments of $130 million upon review of a proof-of-concept study.

tthi

Radian Group (NYSE:RDN): Despite EPS of -19 cents — which messed expectations by 25 cents — shares are up slightly, as the company accrued a net loss of $33.2 million, including a net loss of about $43 million on investments and marks on derivatives contracts. New mortgage insurance business increased 60 percent year-over-year, while inventory of delinquent loans fell off by 21 percent. The loss ratio for the mortgage insurance business remains at about 70 percent.

rdn

Merck & Co. (NYSE:MRK): The FDA has accepted an NDA put forth by the company for the investigational anti-thrombotic medicine vorapaxar for “the secondary prevention of cardiovascular events in patients with a history of heart attack and no history of stroke or transient ischemic attack.” The drug, which Merck acquired in 2009, gives the company its fair share of challenges.

mrk

Don’t Miss: Boeing’s Been a Smooth Ride for Investors Despite Dreamliner Drama.

More Articles About:   , , ,  

More from The Cheat Sheet